E137: Inflation cools, market rips, Ripple/MSFT beat regulators, NATO summit, cocktails of youth
All-In with Chamath, Jason, Sacks & Friedberg Podcast Recap
Published:
Guests: Chris Christie, Nikki Haley
What Happened
Inflation in June eased to 3%, marking the slowest pace in over two years. Despite this cooling, Larry Summers argues for sustained higher interest rates, contrasting with market predictions of rate cuts by December. Chamath Palihapitiya anticipates a significant rise in the equity market, driven by sidelined capital eager to invest in growth assets.
The market is pricing in a soft landing as structural factors like decoupling from China and increased global security expenditures remain inflationary. The tech downturn, beginning in Q1 2022, aligns with the typical six-quarter duration of recessions, hinting at a possible bottoming out soon. In contrast, high operational expenses challenge the profitability of SaaS businesses, despite their high gross margins.
On the regulatory front, Ripple Labs Inc. celebrated a partial victory as a judge ruled that XRP sales on public exchanges did not constitute securities. This decision sent XRP prices soaring by 25%. Meanwhile, the FTC's attempt to block Microsoft's acquisition of Activision Blizzard was thwarted, drawing criticism of Lina Khan's scattershot legal strategy.
In the automotive sector, the supply of electric vehicles surged by 350% this year, leading to a 92-day supply compared to gasoline cars' 54 days. Legacy automakers' production increases face hurdles like lack of charging infrastructure and consumer range anxiety, while Tesla remains the market leader. Government subsidies are perceived as favoring unionized companies over Tesla, raising concerns about industrial policy.
The BRICS countries are launching a gold-based alternative currency, surpassing the G7 in GDP when measured by purchasing power parity. This development, coupled with the Ripple ruling, may bolster Bitcoin's stability and its potential as a future gold standard. Domestically, the U.S. military's ammunition shortages underscore concerns about production capabilities amid NATO's expansion and tensions with Ukraine.
In Science Corner, research into Yamanaka factors reveals potential for reversing aging through reprogramming cells. Harvard and MIT researchers identified six small molecule cocktails that mimic these effects, hinting at future clinical trials for vision loss. This breakthrough is considered one of the most significant since DNA's discovery, with the potential to create products that rejuvenate cells.
The episode also featured lighter moments, including a humorous discussion of alcohol's effects, with noted impacts from champagne. A playful exchange about travel plans to Italy and potential podcast recordings there added to the camaraderie. The episode concluded with witty banter, playfully dubbing the hosts with titles like 'C3P Friedberg' and 'The Sultan of Science.'
Key Insights
- Inflation cooled to 3% in June, the slowest rate in over two years, but Larry Summers warns that interest rates may need to remain higher for longer than market forecasts suggest.
- Ripple Labs Inc. achieved a partial legal victory against the SEC, as the court ruled that XRP sales on public exchanges did not involve securities, causing a 25% rise in XRP's value.
- Electric vehicle supply increased by 350% this year, leading to a 92-day supply, while legacy automakers grapple with challenges like insufficient charging infrastructure and consumer range anxiety.
- Research into reversing aging through Yamanaka factors has led to the discovery of six small molecule cocktails that could rejuvenate cells, potentially leading to groundbreaking clinical applications.
View all All-In with Chamath, Jason, Sacks & Friedberg recaps